ISIngo Sobottka

Ingo Sobottka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ingo Sobottka has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Schwere Kolitis durch Histoplasma capsulatum bei einer Patientin mit Aids

    by T. Buhk, H.-J. Stellbrink, H. Albrecht, I. Sobottka

    Eine 32 Jahre alte HIV-positive Patientin aus Ghana wurde mit einem septischen Krankheitsbild, Diarrhö, Anämie und erheblichem Gewichtsverlust stationär aufgenommen. Initial konnten eine Mycobacterium-tuberculosis- und eine Salmonella-typhi-Infektion diagnostiziert werden. Entsprechende Therapien führten zu einer deutlichen Verbesserung der klinischen Symptomatik. Nach fünf Wochen jedoch kam es zu einem Wiederauftreten von Fieber und Diarrhöen. In Blutkulturen und in histologischen Untersuchungen von koloskopisch gewonnenen Biopsien konnte Histoplasma capsulatum nachgewiesen werden. Die Patientin erholte sich vollständig nach spezifischer antimykotischer Therapie mit Amphotericin B und Itraconazol. Dieser Fallbericht veranschaulicht, dass medizinisches Personal beim Umgang mit immunsupprimierten Patienten aus Endemiegebieten mit den Symptomen sowie den diagnostischen und therapeutischen Maßnahmen dieser seltenen Pilzerkrankung vertraut sein sollte. The case of a thirty-two-year-old female HIV-positive patient from Ghana admitted with a septic illness, diarrhoea, anaemia, and severe weight loss is presented. During an extensive diagnostic work-up Mycobacterium tuberculosis infection and typhoid fever were detected. Specific treatment led to marked improvement in the patient’s condition. However, five weeks later high fever and diarrhoea recurred. Histological examination of biopsies from coloscopy and blood cultures revealed Histoplasma capsulatum. The patient recovered completely following antifungal therapy with amphotericin B and itraconazole. The case presented emphasises the need for medical staff dealing with immunocompromised patients from endemic areas to be aware of symptoms, diagnostic features, and therapeutic measures of this rare fungal infection.


  • Open Access

    In Vitro Activity of Moxifloxacin against Bacteria Isolated from Odontogenic Abscesses

    by Ingo Sobottka, Georg Cachovan, Enno Stürenburg, M. Oliver Ahlers, Rainer Laufs, Ursula Platzer, Dietrich Mack

    We evaluated the antimicrobial susceptibility of 87 pathogens isolated from 37 patients with odontogenic abscesses. The most prevalent bacteria were viridans group streptococci and Prevotella species. Considering all bacterial isolates, 100% were susceptible to amoxicillin-clavulanic acid, 98% were susceptible to moxifloxacin and to levofloxacin, 76% were susceptible to doxycycline, 75% were susceptible to clindamycin, and 69% were susceptible to penicillin.


  • In vitro activity of polyoxin D and nikkomycin Z against Encephalitozoon cuniculi.

    by Ingo Sobottka, Katrin Bartscht, Peter Schäfer, Thomas Weitzel, Justus Schottelius, Nico Kock, Rainer Laufs


  • Acute and long-term humoral immunity following active immunization of rabbits with inacctivated spores of various Encephalitozoon species

    by Ingo Sobottka, Franz Iglauer, Thomas Schüler, Christel Schmetz, Govinda S. Visvesvara, Helmut Albrecht, David A. Schwartz, Norman J. Pieniazek, Katrin Bartscht, Rainer Laufs, et al.

    Microsporidia of the genus Encephalitozoon are increasingly being reported as a cause of severe, often disseminated infections, mainly in patients with acquired immunodeficiency syndrome (AIDS). Immunological identification of each of the three recognized species (E. cuniculi, E. hellem, and E. intestinalis) requires the availability of specific immune sera. All sera available thus far have been generated by direct inoculation of rabbits with virulent microsporidian spores. This study demonstrates for the first time that subcutaneous immunization with inactivated spores of E. cuniculi, E. hellem, or E. intestinalis is capable of generating highly active rabbit hyperimmune sera to the homologous antigens, with maximal titers being 1:5,120, 1:1,280, and 1:2,560, respectively, as determined by the indirect immunofluorescence technique (IIF). Broad cross-reactivity of the rabbit antisera with all heterologous Encephalitozoon antigens was determined by IIF and immunogold electron microscopy; however, only the E. hellem immune serum strongly cross-reacted with spores of Enterocytozoon bieneusi. During the 35-month follow-up period the antibody titers to the homologous antigens declined to 1:640, 1:160, and 1:320, respectively. The observed decay curves for antibody titers against E. cuniculi, E. hellem, and E. intestinalis were fitted using mathematical modeling, resulting in a predicted duration for specific immune responses of about 7 years on average. Knowledge of the magnitude and duration of specific immune responses is a prerequisite for further evaluation of the concept of using inactivated microsporidian spores in the quest for vaccines against microsporidian infections.


    • 1 August 1997
      • Vol. 121  (8) , 874-9

    Diagnosis of Enterocytozoon bieneusi (microsporidia) infections by polymerase chain reaction in stool samples using primers based on the region coding for small-subunit ribosomal RNA.

    by A J Da Silva, F J Bornay-Llinares, C Del A Del Aguila De La Puente, H Moura, J M Peralta, I Sobottka, D A Schwartz, G S Visvesvara, S B Slemenda, N J Pieniazek

    Enterocytozoon bieneusi is the most prevalent microsporidian causing chronic diarrhea in patients with acquired immunodeficiency syndrome. The current methods used for routine diagnosis of infections caused by microsporidia are based on microscopic detection of the microorganism spores in stained smears. We evaluated the usefulness of the polymerase chain reaction (PCR) technique as a tool to diagnose Enterocytozoon bieneusi infections, using the species-specific diagnostic primer pair EBIEF1/EBIER1 on stool samples that were also analyzed by optical microscopy. To perform PCR in such samples, we developed a novel protocol to obtain DNA free of PCR inhibitors. This protocol was based on disruption of spores using glass beads and overnight digestion with proteinase K; final purification was accomplished with the RapidPrep Micro Genomic DNA isolation Kit for Cells and Tissues (Pharmacia Biotech Inc, Piscataway, NJ). We also evaluated this approach on aliquots of a sample fixed in formalin from 1 to 10 days. PATIENTS AND SAMPLES: We evaluated the PCR technique on 64 stool samples obtained from patients with acquired immunodeficiency syndrome who had persistent chronic diarrhea. Patients were from Spain, Brazil, Germany, and the United States. Using this approach, we could confirm the presence of E bieneusi in all 17 positive samples; no false-positive results were observed. We could also amplify E bieneusi DNA in 10 aliquots of one sample fixed up to 10 days in 10% formalin. We conclude that PCR technology is very suitable for species identification of microsporidia in stool samples and may have a potential application in prospective studies in formalin-fixed samples.


    • 1 February 1996
      • Vol. 120  (2) , 189-98

    Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonendemic for Leishmania donovani.

    by H Albrecht, I Sobottka, C Emminger, H Jablonowski, G Just, A Stoehr, T Kubin, B Salzberger, T Lutz, J Van Lunzen

    Visceral leishmaniasis is an important infection in patients infected with human immunodeficiency virus and living in areas endemic for Leishmania sp. Leishmaniasis, however, is rarely suspected in patients residing in nonendemic countries. Retrospective case analysis of 15 patients with human immunodeficiency virus infection and leishmaniasis treated at seven German clinics. The clinicopathological features and the diagnostic role of biopsy and/or cytology as compared to serology were evaluated. All patients were severely immunocompromised. One patient was first diagnosed at autopsy. One patient with mucocutaneous disease was diagnosed by nasal biopsy. All others had amastigotes detected in bone marrow (13/13), liver (3/3), and gastrointestinal mucosa (4/4). Serology was positive in only 6 or 13. Visceral leishmaniasis is an important opportunistic infection in patients with acquired immunodeficiency syndrome and it must be ruled out in every patient with fever and/or pancytopenia and an appropriate travel history. Because serological diagnosis is often insufficient, pathologists must be aware of the association between human immunodeficiency virus infection and leishmaniasis. Diagnosis depends on detection of the parasite in submitted specimens.


    • 1 February 1996
      • Vol. 120  (2) , 173-88

    Pathology of microsporidiosis: emerging parasitic infections in patients with acquired immunodeficiency syndrome.

    by D A Schwartz, I Sobottka, G J Leitch, A Cali, G S Visvesvara

    Microsporidiosis is a group of rapidly emerging protozoan infections that have thus far been reported predominantly from severely immunosuppressed persons with the acquired immunodeficiency syndrome (AIDS). The four genera that have been identified in AIDS patients (Enterocytozoon, Encephalitozoon, Septata, and Pleistophora) are an increasingly common source of both localized and disseminated infections. However, the clinical and pathologic features of these agents are being described with such rapidity that many pathologists are unaware of the histologic, immunologic, and molecular methods for diagnosing these infections. This article summarizes the clinical and morphologic spectrum of the microsporidian species that infect patients with AIDS. Additionally, the role of ultrastructural, immunologic, tissue culture, and molecular techniques for the diagnosis of microsporidian infections are discussed. Clinical and pathologic findings were obtained from patients with AIDS who were evaluated for microsporidian infections at the Grady Memorial Hospital in Atlanta. Selected laboratory studies were performed at the Division of Parasitic Diseases of the Centers for Disease Control and Prevention and at the Department of Physiology at Morehouse University. Additionally, some cases were sent for consultation to the Infectious Disease Pathology service at Emory University. These data were combined with the published studies of microsporidian infection from the medical literature. The pathologic appearance of microsporidian infections in each major organ system (ocular, respiratory, genitourinary, gastrointestinal) is illustrated using routine and special histochemistry and immunofluorescence. The differential diagnostic features of the four genera of microsporidia infecting AIDS patients are illustrated using transmission and scanning electron micrographs from biopsy, autopsy, and tissue culture materials. Cytologic evaluation of body tissues is emphasized as a sensitive method for microsporidian diagnosis. Microsporidian infections can be expected to remain an increasingly important cause of morbidity and mortality in patients with AIDS. It is important that pathologists and microbiologists become acquainted with the clinicopathologic spectrum of these emerging protozoal infections, ensuring timely diagnosis and subsequent treatment.